Safinamide is a MAO-B inhibitor for neurodegenerative disease research
**Background** Neurodegenerative disorders, such as Parkinson’s disease and ischemic stroke, are characterized by the progressive loss of neuronal function and structure. A key factor in the pathogenesis of these conditions…